Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.


TSX:TH - Post by User

Post by retiredRIAon Apr 19, 2021 2:49pm
208 Views
Post# 33023139

voting & shares we own/control

voting & shares we own/controlMy comments re Juniper, PinnacleX, Wino, & my million shares, and the "silent" readers of Stockhouse:

To Juniper:  I understand that we won't get many small shareholders to fill out and vote my mail
To Pinnacle:  When I say about a million shares I "own/control" in previous post, let me explain.  As a retired fee-only RIA for 30 yr I had a "not-to-compete" clause with the buyer of my practice.  That doesn't mean I quit investing and it does not keep me from giving free advice.  I know that these people who got into THTX because of me don't want to go on stockhouse...they expect me to read every post.  My commitment and expectation would be that I am able to get about 750K to vote the way Rusty (see why below).  I will email them ALL with my suggestions and for any SH with 25K shares or larger, email AND call them.  Some of them have thrown away the reports for YEARS and never read or filled them out.  

To Rusty:  I trust you and appreciate your optomistic outlook (ok, nobodies perfect all the time :>).  I also have never seen a "testy" disagreement turn out good for either side.  Let's give this thing one more try to talk to them....if that doesn't work, we will certainly consider threatening them!

To Wino:  I have followed your comments on stockhouse for years and Iand cut and pasted to my friends/sholders.   (most of these are not the type of people who would spend time going to stockhouse (sorry for those 4 or five silent readers who I sent to stockhouse...you are the exceptions!  Between having a local person represent us with THTX, I would want YOU to represent us (maybe add a touch of Qwerty ;>).   Also, with ZOOM you can see the reactions and, of course, that is why it is best to do these discussions in person.  I find that ZOOM meets my needs!


<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse